Influence of SGLT2I on tubulointerstitium in DKD patients with moderate renal dysfunction

被引：0
|
作者：
Murakami, Keisuke [1 ]
Kato, Sawako [1 ]
Sugaya, Takeshi [2 ]
Kuwatsuka, Yachiyo [3 ]
Ando, Masahiko [3 ]
Maruyama, Shoichi [1 ]
机构：
[1] Nagoya Univ, Grad Sch Med, Nagoya, Aichi, Japan
[2] St Marianna Univ, Kawasaki, Japan
[3] Nagoya Univ Hosp, Nagoya, Japan
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2024年 / 39卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
412
引用
收藏
页码：I110 / I111
页数：2
相关论文
共 50 条
  • [31] SGLT2 Inhibition (SGLT2i) Mediated Urinary Glucose Excretion (UGE) Associations with Metabolic and Renal Hemodynamic Parameters
    Lytvyn, Yuliya
    Lytvyn, Andriy
    Muscelli, Elza O.
    Perkins, Bruce A.
    Cherney, David
    Ferrannini, Ele
    DIABETES, 2019, 68
  • [32] SAFETY OF SGLT2 INHIBITORS (SGLT2I) IN PEOPLE OVER 75 YEARS
    Marques Vidas, Maria
    Domenech, Ester
    Martin Testillano, Lucia
    Maroto, Alba
    Lopez, Paula
    Portoles, Jose' M.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2022, 37 : I104 - I104
  • [33] SGLT2i Improves Glycemic Control in Patients With Congenital Severe Insulin Resistance
    Galderisi, Alfonso
    Tamborlane, William
    Taylor, Simeon, I
    Attia, Najya
    Moretti, Carlo
    Barbetti, Fabrizio
    PEDIATRICS, 2022, 150 (01)
  • [34] Impact of SGLT2i on cardiovascular outcomes and heart failure in patients with type 2 diabetes
    Jose Rodriguez, Juan
    Ortega-Paz, Luis
    Brugaletta, Salvatore
    Sabate, Manel
    AIMS MEDICAL SCIENCE, 2018, 5 (01): : 67 - 79
  • [35] KDIGO or UACR: Which Is Key in Affecting Efficacy of SGLT2i in Patients With HF?
    Xu, Xiaoqun
    Zhu, Houyong
    Cai, Long
    Chen, Tielong
    Lin, Kaiqing
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 82 (15) : E135 - E136
  • [36] SGLT2i in Patients with Type 1 Diabetes: Benefits, Risks, and Preventive Strategies
    Ma, Yujin
    Zhao, Qian
    Peng, Huifang
    Nalisa, David Lubasi
    Shan, Pengfei
    Jiang, Hongwei
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2023, 28 (05):
  • [37] BARRIERS AND FACILITATORS FOR SGLT2I UPTAKE AND IMPLEMENTATION - PERSPECTIVES FROM PATIENTS AND CLINICIANS
    O'Hara, Daniel
    Yi, Tae Won
    Morton, Rachael
    Jardine, Meg J.
    NEPHROLOGY, 2023, 28 : 27 - 28
  • [38] GLP-1RA and SGLT2i: Cardiovascular Impact on Diabetic Patients
    Pablo, Aschner
    Evelyn, Blanc
    Claudia, Folino
    Yanina, Morosan A.
    CURRENT HYPERTENSION REVIEWS, 2021, 17 (02) : 149 - 158
  • [39] Effect on Renal Function of SGLT2i Treatment in Hospitalized Patients with Type 2 Diabetes-A Real-World Study
    Bashkin, Amir
    Kruzel-Davila, Etty
    Tzfoni, Itai
    DIABETES, 2023, 72
  • [40] Early Experience with SGLT2i in Systemic Lupus Erythematosus
    Petri, Michelle
    Goldman, Daniel
    Fava, Andrea
    Magder, Larry
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 2941 - 2943
12345